allergy banner

Videos


Articles


Different inflammatory features of asthma according to gut microbiome enterotype

Sohn, K.-H., Choi, S., Jung, J.-W., et al. Allergy. First published: 18 May 2023

Bulk T-Cell Receptor Sequencing Confirms Clonality in Pediatric EoE and Identifies a Food-Specific Repertoire

Janarthanam, R., Kuang, F.L., Zalewski, A., et al. Allergy. First published: 18 May 2023

Sinus inflammation and chronic rhinosinusitis are associated with a diagnosis of new onset asthma in the following year

Schwartz, BS, Pollak, JS, Bandeen-Roche, K, et al. Allergy. First published: 17 May 2023

Allergy to stings and bites from rare or locally important arthropods: worldwide distribution, available diagnostics, and treatment

Sturm, G.J., Boni, E., Antolín-Amérigo, D., et al. Allergy. First published: 16 May 2023

Stepping off the beaten path: A multiomic atlas uncovers novel trajectories of T-cell exhaustion

Falduto, G.H. and Schwartz, D.M. Allergy. First published: 16 May 2023

Glucocorticoids are differentially synthesized along the murine and human respiratory tree

Merk, VM, Renzulli, P, Vrugt, B, et al. Allergy. First published: 12 May 2023

Direct cleavage and activation of gasdermin B by allergens

Panganiban, R.A., Mwase, C., Park, J.-A. and Lu, Q. Allergy. First published: 10 May 2023

Oral prednisone regulates human skin T cells in delayed-type hypersensitivity reaction elicited by diphencyprone

Mehta, H., Jack, C., Maari, C., et al. Allergy. First published: 10 May 2023

Mapping the way to strengthening epithelial barriers: Neuronal circuits in mucus regulation

López-Sanz, C., Jiménez-Saiz, R. and Nuñez-Borque, E. Allergy. First published: 07 May 2023

The future of food allergy: Challenging existing paradigms of clinical practice

Anagnostou, A, Lieberman, J, Greenhawt, M, et al. Allergy. First published: 02 May 2023

Arsenic exposure and pruritus: Evidence from observational, interventional, and mendelian randomization studies

Huang, X, Xiao, Y, Jing, D, et al. Allergy. First published: 02 May 2023

25-hydroxyvitamin D and risk of atopic diseases and infections in early childhood

Brustad, N., Kim, M., Skov, F., et al. Allergy. First published: 02 May 2023

The One Health approach for allergic diseases and asthma

Jutel, M, Mosnaim, GS, Bernstein, JA, et al. Allergy. First published: 29 April 2023

Anti-PD1 therapy outcome can be predicted by pre-therapy IFN-I responsiveness of Teff cells

Grandits, M., Chauhan, J. and Bax, H.J. Allergy. First published: 29 April 2023

Eosinophils from A to Z

Gigon, L, Fettrelet, T, Yousefi, S, Simon, D, Simon, H-U. Allergy. First published: 27 April 2023

The changing global prevalence of asthma and atopic dermatitis

Denton, E., O’Hehir, R.E. and Hew, M. Allergy. First published: 27 April 2023

A multicenter time series study on pollen exposure and COVID-19 infection in five cities in China

Yang, X., Zhang, J., Sima, Y., Zhao, J., Wang, X. and Zhang, L. Allergy. First published: 26 April 2023

An update on recent developments and highlights in food allergy

Locke, A., Hung, L., Upton, J.E.M., O’Mahony, L., Hoang, J. and Eiwegger, T. Allergy. First published: 23 April 2023

The Step-Down approach in children with Cow's Milk Allergy: results of a randomized controlled trial

Nocerino, R., Coppola, S., Carucci, L., et al. Allergy. First published: 23 April 2023

IgE glycosylation is essential for the function of omalizumab

Plattner, K., Augusto, G.S., Muerner, L., et al. Allergy. First published: 19 April 2023

Temperature regulates Rab3a and mast cell-derived exosomal FcεRI to inhibit mast cell activation

Liao, W., Chen, G., Song, L., et al. Allergy. First published: 17 April 2023

Affinity matters for IgE-blocking activity of allergen-specific antibodies

Strobl, M.R., Demir, H., Stadlmayr, G., et al. Allergy. First published: 15 April 2023

Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthma

Papadopoulos, N.G., Szefler, S.J., Bacharier, L.B., et al. Allergy. First published: 14 April 2023

Patient-centred digital biomarkers for allergic respiratory diseases and asthma: the ARIA-EAACI approach

Bousquet, J., Shamji, M.H., Anto, J.M., et al. Allergy. First published: 11 April 2023

Age of onset defines two distinct profiles of atopic dermatitis in adults

Facheris, P., Da Rosa, J.C., Pagan, A.D., et al. Allergy. First published: 09 April 2023

Environmental and Health Hazards by Massive Earthquakes

Bayram, H., Doğan, T.R., Şahin, Ü.A. and Akdis, C.A. Allergy. First published: 07 April 2023

Epithelium-derived cystatin SN inhibits HDM protease activity in allergic asthma

Yao, L., Yuan, X., Fu, H., et al. Allergy. First published: 07 April 2023

In vitro supporting diagnostic tools in plant-food allergy

Antonio, C.J., Clara, L.-M., Reyes, G.-O., et al. Allergy. First published: 06 April 2023

Conditional neutrophil depletion challenges their contribution to mouse models of anaphylaxis

Stackowicz, J., Gillis, C.M., Godon, O., et al. Allergy. First published: 06 April 2023

One in five patients with chronic spontaneous urticaria has IgE to tissue transglutaminase 2

Su, H., Kolkhir, P., Scheffel, J., et al. Allergy. First published: 05 April 2023

Stk4, a key regulator in regulatory T cells homeostasis activity?

Tomei, L. and Céspedes, J.A. Allergy. First published: 05 April 2023

Organ-specific allergen challenges in airway allergy: Current utilities and future directions

Fauquert, JL, Alba-Linero, C, Gherasim, A, et al. Allergy. First published: 01 April 2023

Reply to correspondence “Food allergens to emollients”

Irvine, A.D., Hourihane, J.O.B. and STOP-AD Team. Allergy. First published: 31 March 2023

Innate lymphoid cells type 2 and CD8+ T cells are perturbed in overweight and obese individuals with asthma

Björkander, S., Maier, P., Kere, M., et al. Allergy. First published: 30 March 2023

Maternal and infant serum carotenoids are associated with infantile atopic dermatitis development

Inoue, Y., Yamamoto, Y., Suzuki, S., et al. Allergy. First published: 30 March 2023

Immunomodulatory properties of mesenchymal stem cells: A potential therapeutic strategy for allergic rhinitis

Wang, M, Zhao, N, Wang, C, Jin, Z-B, Zhang, L. Allergy. First published: 28 March 2023

Risk stratification through extensive allergy work-up in COVID-19-mRNA vaccine allergic reactions

Soria, A., Labella, M., Doña, I., et al. Allergy. First published: 27 March 2023

Adherence and persistence in allergen immunotherapy (APAIT): a reporting checklist for retrospective studies

Pfaar, O., Devillier, P., Schmitt, J., et al. Allergy. First published: 27 March 2023

Resolving the aetiology and treatments of allergic diseases

Zhang, L. and Akdis, C.A. Allergy. First published: 25 March 2023

Is exposure to pollen a risk factor for moderate and severe asthma exacerbations?

Annesi-Maesano, I, Cecchi, L, Biagioni, B, et al. Allergy. First published: 24 March 2023

Anti-CD3 Inhibits Circulatory and Tissue-resident Memory CD4 T Cells that Drive Asthma Exacerbations in Mice

Sethi, G.S., Gracias, D.T., Gupta, R.K., et al. Allergy. First published: 23 March 2023

Disparities and inequalities of penicillin allergy in the Asia-Pacific region

Li, P.H., Pawankar, R., Thong, B.Y.H., et al. Allergy. First published: 23 March 2023

Successful usage of a chatbot to standardize and automate history taking in Hymenoptera venom allergy.

Schneider, S., Gasteiger, C., Wecker, et al. Allergy. First published: 22 March 2023

Atopic dermatitis: correlation of distinct risk factors with age of onset in adulthood compared to childhood

Maintz, L., Schmitz, M.-T., Herrmann, N., et al. Allergy. First published: 22 March 2023

Trait profiles in difficult-to-treat asthma: clinical impact and response to systematic assessment

Lin, T., Jonathan, P., Denton, E., et al. Allergy. First published: 20 March 2023

Legends of Allergy: Gianni Marone

Triggiani, M., Casolaro, V. and Stellato, C. Allergy. First published: 19 March 2023

Global Initiative for Asthma (GINA): 30 years of promoting evidence-based asthma care

Yorgancıoğlu, A., Reddel, H.K. Allergy. First published: 18 March 2023

Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both

Pfeffer, P.E., Ali, N., Murray, R., et al. Allergy. First published: 17 March 2023

Severe and refractory anaphylaxis in paediatric intensive care unit

Pouessel, G., Trochu, C., Chagnon, F., et al. Allergy. First published: 17 March 2023

Prescribing patterns of budesonide/formoterol maintenance and reliever therapy in patients with asthma in Sweden

Janson, C., Melén, E., Licht, S.d.F., et al. Allergy. First published: 15 March 2023

pH sensing shapes immune cell function: The role of GPR65 and its implications for allergic disease

de Souza Ferreira, S., Bek, M.K. and Tibbitt, C.A. Allergy. First published: 14 March 2023

Immune Response Evolution in Peanut Epicutaneous Immunotherapy for Peanut-Allergic Children

Bastin, M., Carr, W.W., Davis, C.M., et al. Allergy. First published: 14 March 2023

PM2.5 chemical constituents and allergic rhinitis: Findings from a prospective cohort study in China

Jia, P., Feng, C., Ye, T., Shao, Y. and Yang, S. Allergy. First published: 11 March 2023

Quantitative analysis of urinary cytokines in food-allergic and healthy individuals

Lee, A.S., Parsons, E.S., Chang, I., et al. Allergy. First published: 11 March 2023

An alternative path to oral tolerance

Li, C.H., Kabak, E. and Eiwegger, T. Allergy. First published: 08 March 2023

Acute and Chronic Impacts of Heat Stress on Planetary Health

Sampath, V., Shalakhti, O., Veidis, E., et al. Allergy. First published: 08 March 2023

Dupilumab treatment increases transitional B cells in severe asthma

Lommatzsch, M., Dost, M., Jaishankar, N., et al. Allergy. First published: 08 March 2023

The next generation virus-like particle platform for the treatment of peanut allergy

Sobczak, J.M., Krenger, P.S., Storni, F., et al. Allergy. First published: 08 March 2023

IL-4 drastically decreases deuterosomal and multiciliated cells via alteration in progenitor cell differentiation

Cho, H-J, Chung, YW, Moon, S, et al. Allergy. First published: 08 March 2023

Microglia–neuron interactions promote chronic itch via the NLRP3-IL-1β-GRPR axis

Liu, X, Wang, Y, Zeng, Y, et al. Allergy. First published: 06 March 2023

Determinants of bone density in children with immunoglobulin E-mediated food allergy

Nichols-Vinueza, D.X., Mateja, A., Hatzimemos, A., et al. Allergy. First published: 05 March 2023

Detection of gut and mucosal peptides through TOMAHAQ in healthy individuals

Parsons, E.S., Liu, F., Kaushik, A., et al. Allergy. First published: 05 March 2023

Factors associated with suboptimal response to monoclonal antibodies in severe asthma

Pérez de Llano, L., Marina Malanda, N., Urrutia, I., et al. Allergy. First published: 03 March 2023

In vivo and ex vivo inflammatory responses of the esophageal mucosa to food challenge in adults with eosinophilic esophagitis

Haasnoot, M.L., Kleuskens, M.T.A., Lopez-Rincon, A., et al. Allergy. First published: 03 March 2023

Citations: 138

The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, Aquilina, S, Asero, R, Baker, D, et al. Allergy. 2022; 77: 734– 766

Citations: 98

The role of peripheral blood eosinophil counts in COVID-19 patients

Xie, G, Ding, F, Han, L, Yin, D, Lu, H, Zhang, M. Allergy. 2021; 76: 471– 482

Citations: 70

EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines

Sokolowska, M., Eiwegger, T., Ollert, M., Torres, M.J., Barber, D., Del Giacco, S., et al. Allergy. 2021; 76: 1629-1639

Citations: 68

COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper

Pfaar, O, Klimek, L, Jutel, M, Akdis, C, A, Bousquet, J, Breiteneder, H, et al. Allergy. 2021; 76: 648– 676

Citations: 65

ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – An EAACI-ARIA Position Paper

Klimek, L., Jutel, M., Akdis, C.A., Bousquet, J., Akdis, M., Torres, M.J., et al. Allergy. 2021; 76: 1624-1628

Citations: 61

Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?

Cabanillas, B., Akdis, C.A. and Novak, N. Allergy. 2021; 76: 1617-1618

Citations: 58

Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation

Klimek, L., Novak, N., Cabanillas, B., Jutel, M., Bousquet, J. and Akdis, C.A. Allergy. 2021; 76: 3307-3313

Citations: 55

Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives

Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M., et al. Allergy. 2021; 76: 1640-1660

Citations: 49

EAACI guidelines: Anaphylaxis (2021 update)

Muraro, A, Worm, M, Alviani, C, Cardona, V, DunnGalvin, A, Garvey, L, H, et al et al. Allergy. 2022; 2022; 77: 357– 377

Citations: 43

The role of allergen-specific IgE, IgG and IgA in allergic disease

Shamji, MH, Valenta, R, Jardetzky, T, Verhasselt, V, Durham, S, R, Würtzen, P, A, et al. Allergy. 2021; 76: 3627– 3641

Citations: 43

Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort

Papadopoulos, N.G., Mathioudakis, A.G., Custovic, A., Deschildre, A., Phipatanakul, W., Wong, G., et al. Allergy. 2021; 76: 1765-1775

Citations: 43

Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice

Santos, A.F., Alpan, O. and Hoffmann, H.-J. Allergy. 2021; 76: 2420-2432

Citations: 42

Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines

Agache, I., Song, Y., Alonso-Coello, P., Vogel, Y., Rocha, C., Solà, I., et al. Allergy. 2021; 76: 2337-2353

Citations: 39

In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion

Augusto, G, Mohsen, MO, Zinkhan, S, Liu, X, Vogel, M, Bachmann, MF. Allergy. 2022; 77: 111– 117

Citations: 38

Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: Don't give up on the second dose!

Krantz, M.S., Bruusgaard-Mouritsen, M.A., Koo, G., Phillips, E.J., Stone, C.A., Jr and Garvey, L.H. Allergy. 2021; 76: 2916-2920

Citations: 37

Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19

Guéant, J.-L., Guéant-Rodriguez, R.-M., Fromonot, J., Oussalah, A., Louis, H., Chery, C., et al. Allergy. 2021; 76: 1846-1858

Citations: 35

Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19

Adamo, S., Chevrier, S., Cervia, C., Zurbuchen, Y., Raeber, M.E., Yang, L., et al. Allergy. 2021; 76: 2866-2881

Citations: 34

Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity

Torres, MJ, Trautmann, A, Böhm, I, Scherer, K, Barbaud, A, Bavbek, S, et al. Allergy. 2021; 76: 1325– 1339

Citations: 34

The ingenious mast cell: Contemporary insights into mast cell behavior and function

Dahlin, J.S., Maurer, M., Metcalfe, D.D., Pejler, G., Sagi-Eisenberg, R. and Nilsson, G. Allergy. 2022; 77: 83-99

Citations: 34

Silencing of SARS-CoV-2 with modified siRNA-peptide dendrimer formulation

Khaitov, M., Nikonova, A., Shilovskiy, I., Kozhikhova, K., Kofiadi, I., Vishnyakova, L., et al. Allergy. 2021; 76: 2840-2854

Citations: 34

Interleukin-31: The “itchy” cytokine in inflammation and therapy

Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997

Citations: 32

Predictors of treatment response in chronic spontaneous urticaria

Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981

Citations: 31

Skin tests in urticaria/angioedema and flushing to Pfizer-BioNTech SARS-CoV-2 vaccine: Limits of intradermal testing

Bianchi, L., Biondi, F., Hansel, K., Murgia, N., Tramontana, M. and Stingeni, L. Allergy. 2021; 76: 2605-2607

Citations: 31

Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I

Sokolowska, M, Rovati, GE, Diamant, Z, et al. Allergy. 2021; 76: 114– 130

Citations: 30

Epithelial barrier hypothesis: Effect of the external exposome on the microbiome and epithelial barriers in allergic disease

Celebi Sozener, Z, Ozdel Ozturk, B, Cerci, P, et al. Allergy. 2022; 77: 1418– 1449

Citations: 30

Advances and highlights in asthma in 2021

Agache, I, Eguiluz-Gracia, I, Cojanu, C, et al. Allergy. 2021; 76: 3390– 3407

The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2

Hartley, G.E., Edwards, E.S.J., Varese, N., et al. Allergy. First published: 21 December 2022

Recent developments in the immunopathology of COVID-19

Zhang, H.-p., Sun, Y.-l., Wang, Y.-f., et al. Allergy. First published: 24 November 2022

Immediate hypersensitivity reactions to anti-SARS-CoV-2 neutralizing monoclonal antibodies: a real-life experience

Franceschini, L. and Farsi, A. Allergy. First published: 16 November 2022

The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients

Ungar, B., Hartzell, S., Lozano-Ojalvo, D., et al. Allergy. First published: 01 October 2022

Disproportionate rate of female referrals for suspected COVID-19 vaccine allergies

Chiang, V., Kan, A.K.C., Yim, J.S.H., et al. Allergy. First published: 20 September 2022

Drug hypersensitivity, in vitro tools, biomarkers, and burden with COVID-19 vaccines

Palomares, F., Paris, J.L., Labella, M., Doña, I., Mayorga, C. and Torres, M.J. Allergy. First published: 01 August 2022

Exposure to avian coronavirus vaccines is associated with increased levels of SARS-CoV-2-cross-reactive antibodies

Ardicli, O, Carli, KT, Satitsuksanoa, P, et al. et al. Allergy. First published: 23 July 2022

Urticaria and/or angioedema secondary to mRNA COVID-19 vaccines: Updates from a United States case registry

Anvari, S., Samarakoon, U., Fu, X., et al. Allergy. First published: 16 July 2022

The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma

Kim, J.G., Zhang, A., Rauseo, A.M., et al. Allergy. First published: 15 July 2022

Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity

Worm, M., Alexiou, A., Bauer, A., et al. Allergy. First published: 20 June 2022

Immune-inflammatory proteome of elite ice hockey players before and after SARS-CoV-2 infection

Maurer, D.J., Barletta, E., Heider, A., et al. Allergy. First published: 12 June 2022

T cell recovery and evidence of persistent immune activation 12 months after severe COVID-19

Taeschler, P., Adamo, S., Deng, Y., et al. Allergy. First published: 14 May 2022

Long-term effects of homologous and heterologous SARS-CoV-2 vaccination on humoral and cellular immune responses

Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 14 May 2022

COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumab

Francis, C.H.R., Hearn, A.P., Ratnakumar, S., et al. Allergy. First published: 01 May 2022

Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern

Rothen, D.A., Krenger, P.S., Nonic, A., et al. Allergy. First published: 11 April 2022

Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures

Taeschler, P., Cervia, C., Zurbuchen, Y., et al. Allergy. First published: 01 April 2022

Vaccine based on folded RBD-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants

Gattinger, P., Kratzer, B., Tulaeva, I., et al. Allergy. First published: 31 March 2022

Are health care policies for COVID-19 evidence-based?

Bonini, S. and Fiorito, S. Allergy. First published: 30 March 2022

Virus-related stimuli modulate SARS-CoV-2 entry factor expression in pediatric tonsillar epithelial cells in vitro

Hara, M., Morimoto, N., Watabe, T., et al. Allergy. First published: 29 March 2022

Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines?

Eberlein, B., Sonja, M., Fischer, J., Darsow, U., Biedermann, T. and Brockow, K. Allergy. First published: 10 March 2022

Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization

Cheng, Z.J., Huang, H., Zheng, P., et al. Allergy. First published: 07 March 2022

The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414

Risk factors for severe and critically ill COVID-19 patients: A review

Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455

Vaccines and allergic reactions: the past, the current COVID-19 pandemic, and future perspectives

Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M. et al. Allergy. 2021; 76: 1640-1660

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581

EAACI guidelines: Anaphylaxis (2021 update)

Muraro, A, Worm, M, Alviani, C, et al. Allergy. 2022; 77: 357– 377

Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

Advances and recent developments in asthma in 2020

Cevhertas, L, Ogulur, I, Maurer, DJ, et al. Allergy. 2020; 75: 3124– 3146

The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update

Maurer, M., Magerl, M., Betschel, S., et al. Allergy. First published: 10 January 2022

A compendium answering 150 questions on COVID-19 and SARS-CoV-2

Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541

Management of anaphylaxis due to COVID-19 vaccines in the elderly

Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964

Predictors of treatment response in chronic spontaneous urticaria

Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981

Interleukin-31: The “itchy” cytokine in inflammation and therapy

Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997

Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review

Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016

Eczema herpeticum in atopic dermatitis

Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027

Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study

Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052

Direct assessment of individual skin barrier components by electrical impedance spectroscopy

Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106

Prenatal paraben exposure and atopic dermatitis-related outcomes among children

Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132

Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis

Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154

Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy

Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193

Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine

Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196

Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma

Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202

Identification of Ulocladium chartarum as an important indoor allergen source

Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206

Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis

Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214

Legends of allergy and immunology: Sergio Bonini

Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229

Medical algorithm: Peri-operative management of mastocytosis patients

Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235

Open Access Agreements with Wiley



Check here if your research institution has an agreement with Wiley to make your Original Articles and Review Articles free to read, download and share by everyone: Institutional Payments | Wiley

Free access

17th World Immune Regulation Meeting



As ever, immune regulation is the hottest issue in basic and clinical sciences. With an outstanding list of speakers in this field, WIRM will be one of the key scientific event of the year 2023, being big enough to learn from other disciplines and small enough to personally meet the experts. Check out the website for more information by clicking here.
WIRM

Junior Members Corner



Dear Junior Members,

On Monday, 3 April, board members of the Junior Member Assembly (JMA) had the great opportunity to visit the Allergy Journal offices, and the Swiss Institute of Allergy and Asthma Research (SIAF) in Davos, Switzerland.

In the morning, the Junior Members met with Prof. Cezmi Akdis, Editor-in-Chief of the Allergy Journal, and the Allergy Editorial Team (Laura Alberch, Managing Editor; Anna Globinska, Graphics Editor; Rüya Kilic Ögülür, Online Media Editor) to discuss state of the art and future perspectives regarding the fruitful collaboration between Allergy journal and JMA. Collaborations on numerous ambitious projects have been discussed, specifically focusing on educational programs.

After the meeting, the JM were guided through the SIAF Labs and facilities, and they met SIAF Principal Investigators and research teams.

After the lunch with an amazing mountain and lake view, JM and SIAF researchers joined together for an informative and pleasant symposium, where they discussed cutting-edge scientific ideas:

- Mattia Giovannini: Anaphylaxis Phenotypes in Children
- Cristina Boccabella: Small Airways Disease (SAD) in severe asthma as a novel endpoint and distinct target for Mepolizumab (SASAM Study)
- Riccardo Castagnoli: Translational approaches to dissect microbiota-host interactions in inborn errors of immunity
- Rubén Fernández-Santamaría: Cellular recognition of drug antigenic determinants. New parameters to improve in vitro tests.
- Yasutaka Mitamura: Diving deep into skin immunology: Novel subsets of macrophages, dendritic cells, T cells and fibroblasts and their interactions in atopic dermatitis
- Urszula Radzikowska: Immune metabolism
- Ismail Ogülür: Food emulsifiers, dishwasher detergents and epithelitis
- Duygu Yazici: Organochips (organ-on-a-chips) and future of the epithelial barrier research
- Damir Zhakparov: Feature Selection Workflow for RNAseq Datasets with regard to Biomedical Relevance
- Yagiz Pat: Organoids and future of epithelial barrier research
- Manal Bel Imam: B cells, antibodies and biomarkers in eosinophilic esophagitis.
- Pattraporn Satitsuksanoa: Distinct mechanisms of induced and natural immune tolerance

For the Junior Members, it has been an unforgettable experience!

We encourage all the JM to attend the World Immune Regulation Meeting (WIRM) 2023 that will be held in Davos from 5 to 8 July 2023 (more info available at https://www.wirm.ch/).It will be a wonderful opportunity to meet all the SIAF researchers and other international experts in the beautiful city of Davos.

Best regards,
The Junior Member Assembly


EAACI Patients Organisation Committee Corner




The EAACI Patients Organisation Committee (POC) aims to be the patients reference body in the field of Allergology, representing patients of all nationalities across the globe, and promoting patient-centred healthcare in the specialty. The POC is currently comprised of 33 members which are patient support organizations working at the local, national, regional and international levels. The committee aims to build cross-sector alliances and working collaboratively with EAACI members, policy makers, and industry representatives. Activities undertaken by the POC include:
  • Providing EAACI with the patient and carer real life experience of living with allergic diseases and asthma
  • Engaging and contributing patient perspectives through participation in EAACI Sections, Conferences, Interest Groups, Working Groups, Committees, and Task Forces
  • Building cross-sector alliances and promoting collaboration between patient group members and other EAACI members, policy makers, and industry representatives with specific focus on priorities that are common across geographies
  • Bringing patient organisations from around the world to discuss, align and promote patient-organisation led education, advocacy and research initiatives
  • Building broad based awareness of the burden of allergic diseases and asthma

The POC meets 4 to 6 times per year virtually and pre-covid, would meet in person at one EAACI conference per year and focused meetings such as FAAM and PAAM. These sessions provide the forum to discuss common issues, align on actions and share best practices. Most recently, they have provided a good platform to discuss international efforts at CODEX and engage in global research priorities.

EAACI POC is truly international in its focus with representation from 30 countries listed at this link. With this representation, it is well positioned to work with EAACI in support of patient needs on a global scale.



EAACI POC

Photo from FAAM 2018
Photo credit: Yanne Boloh